Journal
CONTROLLED CLINICAL TRIALS
Volume 25, Issue 2, Pages 203-222Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cct.2003.11.007
Keywords
study organization; study management; chemoprevention; prostate cancer; finasteride
Funding
- NCI NIH HHS [CA38926, 5U10-CA37429] Funding Source: Medline
Ask authors/readers for more resources
The Prostate Cancer Prevention Trial is a randomized double blind chemoprevention trial of 18,882 men. It is designed to test the difference in the histologically proven prostate cancer prevalence between a group of participants given finasteride and another given placebo for 7 years. We present an overview of the study design, details of the administrative structure of the study and a description of the successful implementation of the accrual phase. (C) 2004 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
